Production (Stage)
Assembly Biosciences, Inc.
ASMB
$13.52
-$0.04-0.30%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 91.03M | 112.08M | 94.95M | 109.22M | 112.98M |
Total Receivables | 400.00K | 400.00K | 400.00K | 400.00K | 43.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 4.10M | 3.02M | 2.86M | 3.31M | 4.15M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 95.53M | 115.50M | 98.21M | 112.93M | 117.17M |
|
|||||
Total Current Assets | 95.53M | 115.50M | 98.21M | 112.93M | 117.17M |
Net Property, Plant & Equipment | 3.18M | 3.35M | 1.74M | 2.08M | 2.40M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 312.00K | 312.00K | 312.00K | 312.00K | 312.00K |
Total Assets | 99.02M | 119.17M | 100.26M | 115.32M | 119.88M |
|
|||||
Total Accounts Payable | 875.00K | 585.00K | 1.34M | 801.00K | 727.00K |
Total Accrued Expenses | 4.41M | 9.14M | 6.35M | 6.12M | 4.11M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 529.00K | 461.00K | 1.33M | 1.30M | 1.15M |
Total Finance Division Other Current Liabilities | 40.82M | 37.62M | 32.62M | 33.06M | 32.77M |
Total Other Current Liabilities | 40.82M | 37.62M | 32.62M | 33.06M | 32.77M |
Total Current Liabilities | 46.63M | 47.80M | 41.64M | 41.27M | 38.75M |
|
|||||
Total Current Liabilities | 46.63M | 47.80M | 41.64M | 41.27M | 38.75M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 2.49M | 2.63M | 113.00K | 451.00K | 791.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 22.76M | 35.38M | 32.51M | 38.92M | 47.74M |
Total Liabilities | 71.88M | 85.81M | 74.26M | 80.64M | 87.28M |
|
|||||
Common Stock & APIC | 862.13M | 859.50M | 841.75M | 840.95M | 827.67M |
Retained Earnings | -834.74M | -825.93M | -815.59M | -805.98M | -794.83M |
Treasury Stock & Other | -253.00K | -211.00K | -156.00K | -293.00K | -239.00K |
Total Common Equity | 27.13M | 33.36M | 26.00M | 34.68M | 32.60M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 27.13M | 33.36M | 26.00M | 34.68M | 32.60M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 27.13M | 33.36M | 26.00M | 34.68M | 32.60M |
|